Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in stroke prevention


Phase N/A Results

Eligibility Criteria

Inclusion Criteria

< 65 years of age, at least one transient atherothrombotic cerebral event.

Exclusion Criteria

Residual neurologic deficits from a previous stroke, cardiac valvular disease, atrial fibrillation, non-atheromatous vascular disease, hemodynamic crises, hypertensive encephalopathy, hematologic disease, increased hyperviscosity of the blood, accompanied migraine or partial epileptic seizures, hypoglycemia and other metabolic disorders, bad physical condition due to other illness.